跳至主要内容
临床试验/ACTRN12610000978066
ACTRN12610000978066招募中未知

The effects of a naturally occurring combination of omega-3s on children and adolescents with hyperactivity and inattention

Pharmalink0 个研究点目标入组 160 人开始时间: 2010年11月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
Pharmalink
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
6 Years 至 14 Years(—)
性别
All

入选标准

  • 1. Healthy non-smoking males and females aged between 7 and 13 years.
  • 2. DSM-IV ADHD rating score above 15
  • 3. Fluent in English
  • 4. Parent/legal guardian provide a personally signed and dated informed consent indicating that they have been informed of all pertinent aspects of the trial.
  • 5. Participant provide a signed copy of a simplified children’s consent form

排除标准

  • 1. Medical diagnosis other than ADHD, Oppositional defiance disorder or similar behavioural disorder
  • 2. Currently taking any medication (other than stimulants if a formal diagnosis of ADHD or other behavioural disorder is present)
  • 3. History of / current heart disease or high blood pressure or diabetes
  • 4. Health conditions that would affect food metabolism including the following: food allergies, kidney disease, liver disease and/or gastrointestinal diseases (e.g. Irritable bowel syndrome, coeliac disease, peptic ulcers)
  • 5. Pregnant or breast feeding
  • 6. Unable to participate in all scheduled visits, treatment plan, tests and other trial procedures according to the protocol
  • 7. Allergy to shellfish
  • 8. Epilepsy or photosensitive

研究者

发起方
Pharmalink

相似试验